The Netherlands: Trial with three vaccines against HPAI
Wageningen Bioveterinary Research (WBVR) has started a trial with avian influenza vaccination.
Vaccines against avian flu of three different pharmaceutical companies are tested. In the trial vaccines against the current H5 viruses are tested in laying hens. More information about the potential vaccines against avian influenza is required before these can be applied in the field. The research is done under commission of the Dutch ministry of Agriculture, Nature and Food Quality.
This first vaccine trial is performed in the animal facilities in the high containment unit of WBVR. The vaccines were developed by three different pharmaceutical companies; the tested vaccines are based on different technologies. The trial will run for about three months after which data will be analysed. Final results are not expected before the second half of December.
Avian influenza vaccines have to protect against disease but also need to prevent the spread of the virus.
